Full Breakdown
Concerns Over ADHD Treatment in Private Clinics Prompt Regulatory Changes
2/28/2026, 9:15:38 PM
Rising Risks in ADHD Treatment
Doctors have raised alarms about the safety of children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) at poorly regulated private clinics. These clinics often prescribe powerful stimulants, such as methylphenidate (commonly known as Ritalin), without conducting essential physical examinations. The trend towards remote-only assessments has led to what some clinicians describe as "widespread and unsafe practice," where diagnoses and prescriptions occur via video consultations.
In response to these concerns, health authorities in Greater Manchester have begun to revise prescribing protocols, mandating face-to-face assessments to ensure the safety of young patients. Rashad Nawaz, a consultant paediatrician with clinics in Manchester and Liverpool, has highlighted the risks associated with this practice, noting that he has treated children with undiagnosed heart conditions who were prescribed stimulants by national online providers without any in-person evaluations.
Background on ADHD Medication Guidelines
The National Institute for Health and Care Excellence (NICE) guidelines stipulate that a comprehensive physical assessment, including a cardiovascular history and a physical examination, is essential before initiating ADHD treatment. Nawaz's observations underscore the potential dangers of neglecting these guidelines. He reported identifying three children in the past year with previously unknown heart murmurs, one of whom was diagnosed with a ventricular septal defect (VSD), a serious condition that could lead to future health complications.
Regulatory Response and New Protocols
In light of these findings, NHS Greater Manchester has implemented a new "safety first" pathway aimed at enhancing patient safety. Prof Manisha Kumar, the region’s chief medical officer, emphasized the necessity of prioritizing children's safety, stating, "We are now implementing new pathways that require face-to-face assessments and physical health checks before ADHD medication is prescribed." This new system allows families to maintain their right to choose private care while ensuring that providers cannot initiate treatment without demonstrating that a thorough in-person clinical assessment has occurred.
Criticism of Current Practices
Critics of the current system, including Nawaz, argue that many large national private providers do not conduct face-to-face consultations, relying instead on minimal health checks performed by parents. Nawaz noted that this approach is inadequate, as it fails to capture critical medical histories, such as a family history of congenital heart disease, which can significantly impact treatment decisions. He expressed concern over the "deskilling" of healthcare professionals, where those trained primarily in adult care are treating children without sufficient pediatric experience.
Verbatim Quotes
- “None of them had symptoms, but the one with a VSD may do in the future,” — Rashad Nawaz, Consultant Paediatrician
- “children’s safety has to come first” — Prof Manisha Kumar, Chief Medical Officer, NHS Greater Manchester
- “Most of the big national private providers … do not actually see children face to face,” — Rashad Nawaz, Consultant Paediatrician
Conclusion
The shift towards more stringent regulations in Greater Manchester reflects a growing recognition of the risks associated with ADHD treatment in poorly regulated private clinics. As the healthcare landscape evolves, the emphasis on thorough physical assessments aims to safeguard the health of children receiving ADHD medication.
